Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Buzaid

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Seminars in Oncology|December 1, 1994
Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanomaA C Buzaid, S S Legha
Seminars in Oncology|February 1, 1989
Therapeutic options in renal cell carcinomaA C Buzaid, M B Todd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Management of refractory myeloma: a reviewA C Buzaid, B G Durie
Clinics in Plastic Surgery|August 15, 2000
Clinical classification and stagingJ E Gershenwald, D Fischer, A C Buzaid
Cancer|August 15, 1995
Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanomaP Anderlini, A C Buzaid, S S Legha
American Journal of Clinical Oncology|June 1, 1991
High-dose cisplatin plus WR-2721 in a split course in metastatic malignant melanoma. A phase II studyA C Buzaid, J Murren, H J Durivage
Melanoma Research|April 1, 1997
A phase II study of interferon-alpha 2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanomaM Z Schultz, A C Buzaid, W J Poo
Cancer|September 15, 1991
High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanomaA C Buzaid, J R Murren, H J Durivage
The American Journal of Medicine|June 1, 1986
Management of myelodysplastic syndromesA C Buzaid, H S Garewal, B R Greenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
13-cis-retinoic acid in myelodysplastic syndromesB R Greenberg, A C Buzaid, F L Meyskens
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Seminars in Oncology|December 1, 1994
Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanomaA C Buzaid, S S Legha
Seminars in Oncology|February 1, 1989
Therapeutic options in renal cell carcinomaA C Buzaid, M B Todd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Management of refractory myeloma: a reviewA C Buzaid, B G Durie
Clinics in Plastic Surgery|August 15, 2000
Clinical classification and stagingJ E Gershenwald, D Fischer, A C Buzaid
Cancer|August 15, 1995
Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanomaP Anderlini, A C Buzaid, S S Legha
American Journal of Clinical Oncology|June 1, 1991
High-dose cisplatin plus WR-2721 in a split course in metastatic malignant melanoma. A phase II studyA C Buzaid, J Murren, H J Durivage
Melanoma Research|April 1, 1997
A phase II study of interferon-alpha 2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanomaM Z Schultz, A C Buzaid, W J Poo
Cancer|September 15, 1991
High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanomaA C Buzaid, J R Murren, H J Durivage
The American Journal of Medicine|June 1, 1986
Management of myelodysplastic syndromesA C Buzaid, H S Garewal, B R Greenberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
13-cis-retinoic acid in myelodysplastic syndromesB R Greenberg, A C Buzaid, F L Meyskens
Pageof 8